Upstream Bio (UPB) Change in Account Payables (2023 - 2026)

Upstream Bio's Change in Account Payables history runs 4 years deep, the most recent figure standing at -$1.0 million for Q1 2026.

• In Q1 2026, Change in Account Payables fell 242.9% year-over-year to -$1.0 million; the TTM figure through Mar 2026 stood at -$3.0 million (down 189.98% YoY), while the FY2025 annual figure was -$1.3 million, down 163.51% from the prior year.
• Change in Account Payables for Q1 2026 stood at -$1.0 million, up from -$1.2 million in the prior quarter.
• The five-year high for Change in Account Payables was $3.7 million in Q2 2024, with the low at -$2.2 million in Q2 2025.
• The 4-year median for Change in Account Payables is -$394500.0 (2024), against an average of $147700.0.
• The sharpest annual moves came in 2025 and 2026: Change in Account Payables surged 905.17% in 2025, then tumbled 242.9% in 2026.
• Upstream Bio's Change in Account Payables stood at $1.8 million in 2023, then sank by 149.57% to -$871000.0 in 2024, then sank by 40.76% to -$1.2 million in 2025, then gained by 17.13% to -$1.0 million in 2026.
• Business Quant data shows UPB's Change in Account Payables at -$1.0 million in Q1 2026, -$1.2 million in Q4 2025, and $1.4 million in Q3 2025.